307 related articles for article (PubMed ID: 21871279)
21. The development of aortic insufficiency in left ventricular assist device-supported patients.
Cowger J; Pagani FD; Haft JW; Romano MA; Aaronson KD; Kolias TJ
Circ Heart Fail; 2010 Nov; 3(6):668-74. PubMed ID: 20739615
[TBL] [Abstract][Full Text] [Related]
22. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients.
Ochiai Y; McCarthy PM; Smedira NG; Banbury MK; Navia JL; Feng J; Hsu AP; Yeager ML; Buda T; Hoercher KJ; Howard MW; Takagaki M; Doi K; Fukamachi K
Circulation; 2002 Sep; 106(12 Suppl 1):I198-202. PubMed ID: 12354733
[TBL] [Abstract][Full Text] [Related]
23. Trans-catheter closure of the native aortic valve with an Amplatzer Occluder to treat progressive aortic regurgitation after implantation of a left-ventricular assist device.
Grohmann J; Blanke P; Benk C; Schlensak C
Eur J Cardiothorac Surg; 2011 Jun; 39(6):e181-3. PubMed ID: 21377889
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for aortic insufficiency and aortic valve replacement after the arterial switch operation.
Lange R; Cleuziou J; Hörer J; Holper K; Vogt M; Tassani-Prell P; Schreiber C
Eur J Cardiothorac Surg; 2008 Oct; 34(4):711-7. PubMed ID: 18684635
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics.
Parikh KS; Mehrotra AK; Russo MJ; Lang RM; Anderson A; Jeevanandam V; Freed BH; Paul JD; Karol J; Nathan S; Shah AP
JACC Cardiovasc Interv; 2013 Jan; 6(1):84-9. PubMed ID: 23347865
[TBL] [Abstract][Full Text] [Related]
26. Changes in renal function after implantation of continuous-flow left ventricular assist devices.
Hasin T; Topilsky Y; Schirger JA; Li Z; Zhao Y; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Joyce L; Daly R; Park SJ; Kushwaha SS
J Am Coll Cardiol; 2012 Jan; 59(1):26-36. PubMed ID: 22192665
[TBL] [Abstract][Full Text] [Related]
27. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
[TBL] [Abstract][Full Text] [Related]
28. Changes in myocardial collagen content before and after left ventricular assist device application in dilated cardiomyopathy.
Liang H; Müller J; Weng YG; Wallukat G; Fu P; Lin HS; Bartel S; Knosalla C; Pregla R; Hetzer R
Chin Med J (Engl); 2004 Mar; 117(3):401-7. PubMed ID: 15043781
[TBL] [Abstract][Full Text] [Related]
29. Mitral valve repair in heart failure: five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial.
Acker MA; Jessup M; Bolling SF; Oh J; Starling RC; Mann DL; Sabbah HN; Shemin R; Kirklin J; Kubo SH
J Thorac Cardiovasc Surg; 2011 Sep; 142(3):569-74, 574.e1. PubMed ID: 21269649
[TBL] [Abstract][Full Text] [Related]
30. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy.
Topilsky Y; Pereira NL; Shah DK; Boilson B; Schirger JA; Kushwaha SS; Joyce LD; Park SJ
Circ Heart Fail; 2011 May; 4(3):266-75. PubMed ID: 21303989
[TBL] [Abstract][Full Text] [Related]
31. Proximal thoracic aorta dimensions after continuous-flow left ventricular assist device implantation: Longitudinal changes and relation to aortic valve insufficiency.
Fine NM; Park SJ; Stulak JM; Topilsky Y; Daly RC; Joyce LD; Pereira NL; Schirger JA; Edwards BS; Lin G; Kushwaha SS
J Heart Lung Transplant; 2016 Apr; 35(4):423-32. PubMed ID: 26632029
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of De Novo Aortic Valve Insufficiency in Patients After HeartWare VAD Implantation with an Intermittent Low-Speed Algorithm.
Saeed D; Westenfeld R; Maxhera B; Keymel S; Sherif A; Sadat N; Petrov G; Albert A; Lichtenberg A
ASAIO J; 2016; 62(5):565-70. PubMed ID: 27195744
[TBL] [Abstract][Full Text] [Related]
33. Does postoperative blood pressure influence development of aortic regurgitation following continuous-flow left ventricular assist device implantation?†.
Patil NP; Mohite PN; Sabashnikov A; Dhar D; Weymann A; Zeriouh M; Koch A; Garcia-Saez D; Zych B; Hards R; Hedger M; De Robertis F; Moza A; Bahrami T; Amrani M; Rahman-Haley S; Popov AF; Banner N; Simon AR
Eur J Cardiothorac Surg; 2016 Mar; 49(3):788-94. PubMed ID: 26108216
[TBL] [Abstract][Full Text] [Related]
34. Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement.
Ruel M; Kapila V; Price J; Kulik A; Burwash IG; Mesana TG
Circulation; 2006 Jul; 114(1 Suppl):I541-6. PubMed ID: 16820634
[TBL] [Abstract][Full Text] [Related]
35. Risk analysis of bloodstream infection during long-term left ventricular assist device support.
Toda K; Yonemoto Y; Fujita T; Shimahara Y; Sato S; Nakatani T; Kobayashi J
Ann Thorac Surg; 2012 Nov; 94(5):1387-93. PubMed ID: 22571882
[TBL] [Abstract][Full Text] [Related]
36. Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation.
Piacentino V; Troupes CD; Ganapathi AM; Blue LJ; Mackensen GB; Swaminathan M; Felker GM; Stafford-Smith M; Lodge AJ; Rogers JG; Milano CA
Ann Thorac Surg; 2011 Oct; 92(4):1414-8; discussion 1418-9. PubMed ID: 21958790
[TBL] [Abstract][Full Text] [Related]
37. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy.
Hetzer R; Müller JH; Weng YG; Loebe M; Wallukat G
J Thorac Cardiovasc Surg; 2000 Nov; 120(5):843-53. PubMed ID: 11044309
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and durability of central oversewing for treatment of aortic insufficiency in patients with continuous-flow left ventricular assist devices.
Schechter MA; Joseph JT; Krishnamoorthy A; Finet JE; Ganapathi AM; Lodge AJ; Milano CA; Patel CB
J Heart Lung Transplant; 2014 Sep; 33(9):937-42. PubMed ID: 24997496
[TBL] [Abstract][Full Text] [Related]
39. Preoperative risk factors for mortality after biventricular assist device implantation.
Zahr F; Ootaki Y; Starling RC; Smedira NG; Yamani M; Thuita L; Fukamachi K
J Card Fail; 2008 Dec; 14(10):844-9. PubMed ID: 19041048
[TBL] [Abstract][Full Text] [Related]
40. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B
J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
